Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Leslie I Grad & Neil R Cashman. (2014) Prion-like activity of Cu/Zn superoxide dismutase. Prion 8:1, pages 33-41.
Read now
Read now
Will
C. Guest, J.
Maxwell Silverman, Edward Pokrishevsky, Megan
A. O'Neill, Leslie
I. Grad & Neil
R. Cashman. (2011) Generalization of the Prion Hypothesis to Other Neurodegenerative Diseases: An Imperfect Fit. Journal of Toxicology and Environmental Health, Part A 74:22-24, pages 1433-1459.
Read now
Read now
Articles from other publishers (31)
Abdullah Ashraf Hamad, Basma Ehab Amer, Aya Mustafa AL Mawla, Elarbi Goufa, Maya Magdy Abdelwahab & Ibrahim Serag. (2023) Clinical characteristics, course, and outcomes of amyotrophic lateral sclerosis overlapping with pregnancy: a systematic review of 38 published cases. Neurological Sciences 44:12, pages 4219-4231.
Crossref
Crossref
Shawn C. C. Hsueh, Mark Nijland, Xubiao Peng, Benjamin Hilton & Steven S. Plotkin. (2022) First Principles Calculation of Protein–Protein Dimer Affinities of ALS-Associated SOD1 Mutants. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Israel Ben-Dor, Crystal Pacut, Yuval Nevo, Eva L. Feldman & Benjamin E. Reubinoff. (2021) Characterization of C9orf72 haplotypes to evaluate the effects of normal and pathological variations on its expression and splicing. PLOS Genetics 17:3, pages e1009445.
Crossref
Crossref
Kusum Yadav, Anurag Yadav, Priyanka Vashistha, Veda P. Pandey & Upendra N. Dwivedi. (2019) Protein Misfolding Diseases and Therapeutic Approaches. Current Protein & Peptide Science 20:12, pages 1226-1245.
Crossref
Crossref
Viviana Greco, Patrizia Longone, Alida Spalloni, Luisa Pieroni & Andrea Urbani. 2019. Mitochondria in Health and in Sickness. Mitochondria in Health and in Sickness
71
82
.
Marie RyanMark HeverinMark A. DohertyNicola DavisEmma M. CorrAlice VajdaNiall PenderRussell McLaughlinOrla Hardiman. (2018) Determining the incidence of familiality in ALS. Neurology Genetics 4:3.
Crossref
Crossref
Sabrina K. Hollinger, Ike S. Okosun & Cassie S. Mitchell. (2016) Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?. Frontiers in Neurology 7.
Crossref
Crossref
Cassie S. Mitchell, Sabrina K. Hollinger, Shivani D. Goswami, Meraida A. Polak, Robert H. Lee & Jonathan D. Glass. (2015) Antecedent Disease Is Less Prevalent in Amyotrophic Lateral Sclerosis. Neurodegenerative Diseases 15:2, pages 109-113.
Crossref
Crossref
D. Allan Butterfield, Liqing Gu, Fabio Di Domenico & Renã A.S. Robinson. (2014) Mass spectrometry and redox proteomics: Applications in disease. Mass Spectrometry Reviews 33:4, pages 277-301.
Crossref
Crossref
Marzia PerluigiRaffaella CocciaD. Allan Butterfield. (2012) 4-Hydroxy-2-Nonenal, a Reactive Product of Lipid Peroxidation, and Neurodegenerative Diseases: A Toxic Combination Illuminated by Redox Proteomics Studies. Antioxidants & Redox Signaling 17:11, pages 1590-1609.
Crossref
Crossref
D. Allan ButterfieldMarzia PerluigiTanea ReedTasneem MuharibChristopher P. HughesRenã A.S. RobinsonRukhsana Sultana. (2012) Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications. Antioxidants & Redox Signaling 17:11, pages 1610-1655.
Crossref
Crossref
Minhee KimEunhee Kong. (2012) Genetic Polymorphisms of Cytochrome P450 2C19 in Functional Dyspeptic Patients Treated with Cimetidine. The Korean Journal of Physiology & Pharmacology 16:5, pages 339.
Crossref
Crossref
Leslie I. GradWill C. GuestAnat YanaiEdward PokrishevskyMegan A. O'NeillEbrima GibbsValentyna SemenchenkoMasoud YousefiDavid S. Wishart, Steven S. Plotkin & Neil R. Cashman. (2011) Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proceedings of the National Academy of Sciences 108:39, pages 16398-16403.
Crossref
Crossref
Luis B Tovar-y-Romo, Luz Diana Santa-Cruz & Ricardo Tapia. (2009) Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis. Molecular Neurodegeneration 4:1.
Crossref
Crossref
Rodrigo López-González, Philip Kunckles & Iván Velasco. (2009) Transient Recovery in a Rat Model of Familial Amyotrophic Lateral Sclerosis after Transplantation of Motor Neurons Derived from Mouse Embryonic Stem Cells. Cell Transplantation 18:10-11, pages 1171-1181.
Crossref
Crossref
Clive E. Sabel, Paul Boyle, Gillian Raab, Markku Löytönen & Paula Maasilta. (2009) Modelling individual space–time exposure opportunities: A novel approach to unravelling the genetic or environment disease causation debate. Spatial and Spatio-temporal Epidemiology 1:1, pages 85-94.
Crossref
Crossref
F. J. F. Broeyer, B. E. van Aken, J. Suzuki, M. J. B. Kemme, H. C. Schoemaker, A. F. Cohen, Y. Mizushima & J. Burggraaf. (2008) The pharmacokinetics and effects of a long-acting preparation of superoxide dismutase (PC-SOD) in man. British Journal of Clinical Pharmacology 65:1, pages 22-29.
Crossref
Crossref
R. Gastl & A.C. Ludolph. (2007) Amyotrophe LateralskleroseAmyotrophic lateral sclerosis. Der Nervenarzt 78:12, pages 1449-1459.
Crossref
Crossref
Ahmad Galaleldeen & P. John Hart. 2007. Protein Misfolding, Aggregation, and Conformational Diseases. Protein Misfolding, Aggregation, and Conformational Diseases
327
344
.
Deniz Tuncel, Nursel Aydin, Pelin Aribal Kocatürk, Güzin Özelçi Kavas & Sevda Sarikaya. (2006) Red cell superoxide dismutase activity in sporadic amyotrophic lateral sclerosis. Journal of Clinical Neuroscience 13:10, pages 991-994.
Crossref
Crossref
Josep Gamez, Marc Corbera-Bellalta, Gisela Nogales, Nuria Raguer, Elena García-Arumí, Mercè Badia-Canto, E. Lladó-Carbó & José Álvarez-Sabín. (2006) Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: Should all sporadic ALS cases also be screened for SOD1?. Journal of the Neurological Sciences 247:1, pages 21-28.
Crossref
Crossref
D. Allan Butterfield, Hafiz Mohmmad Abdul, Shelley Newman & Tanea Reed. (2006) Redox proteomics in some age-related neurodegenerative disorders or models thereof. NeuroRX 3:3, pages 344-357.
Crossref
Crossref
P.-F. Pradat & G. Bruneteau. (2006) Quels sont les critères cliniques de la sclérose latérale amyotrophique en fonction des formes cliniques ?. Revue Neurologique 162, pages 29-33.
Crossref
Crossref
Ettore Beghi. (2006) 127th ENMC International Workshop: Implementation of a European Registry of ALS Naarden, The Netherlands, 8–10 October 2004. Neuromuscular Disorders 16:1, pages 46-53.
Crossref
Crossref
Marzia Perluigi, H. Fai Poon, Kenneth Hensley, William M. Pierce, Jon B. Klein, Vittorio Calabrese, Carlo De Marco & D. Allan Butterfield. (2005) Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice-A model of familial amyotrophic lateral sclerosis. Free Radical Biology and Medicine 38:7, pages 960-968.
Crossref
Crossref
Jun Xie, Keytam S. Awad & Qing Guo. (2005) RNAi knockdown of Par-4 inhibits neurosynaptic degeneration in ALS-linked mice. Journal of Neurochemistry 92:1, pages 59-71.
Crossref
Crossref
Lucie I. BruijnTimothy M. MillerDon W. Cleveland. (2004) UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS. Annual Review of Neuroscience 27:1, pages 723-749.
Crossref
Crossref
Gisela Nogales-Gadea, Elena Garcia-Arumi, Antonio L. Andreu, Carlos Cervera & Josep Gamez. (2004) A novel exon 5 mutation (N139H) in the SOD1 gene in a Spanish family associated with incomplete penetrance. Journal of the Neurological Sciences 219:1-2, pages 1-6.
Crossref
Crossref
YUSIMI SOBRINO-BONILLA. (2004) Caring for a Laboring Women With Amyotrophic Lateral Sclerosis. MCN, The American Journal of Maternal/Child Nursing 29:4, pages 243-247.
Crossref
Crossref
Véronique Mayeux, Philippe Corcia, Gérard Besson, Hélène‐Farnase Jafari‐Schluep, Valérie Briolotti & William Camu. (2003) N19S, a new SOD1 mutation in sporadic amyotrophic lateral sclerosis: No evidence for disease causation. Annals of Neurology 53:6, pages 815-818.
Crossref
Crossref
Markus Weber, Andrew Eisen, Heather G. Stewart, Peter M. Andersen & Nobuyuki Hirota. (2001) The physiological basis of conduction slowing in ALS patients homozygous for the D90A CuZn-SOD mutation. Muscle & Nerve 24:1, pages 89-97.
Crossref
Crossref